Print

Rexahn Pharmaceuticals, Inc. Provides Update on 2012 Strategic Goals  
9/4/2012 10:33:47 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today provided an update on its strategic business goals for 2012.
//-->